Geller Advisors LLC Acelrx Pharmaceuticals Inc Transaction History

Geller Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$1.7 - $2.35 $467,500 - $646,250	-275,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$1.75 - $5.5 $306,250 - $962,500	175,000 Added 175.0%	275,000 $557,000
Q3 2017 Nov 13, 2017	BUY	$2.9 - $4.6 $290,000 - $459,999	100,000	100,000 $460,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Geller Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Geller Advisors LLC with notifications on news.